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Electrically-generated cold atmospheric plasma is being intensively researched for 
novel applications in biology and medicine. Significant attention is being given to 
reactive oxygen and nitrogen species (RONS), initially generated upon plasma-air 
interactions, and subsequently delivered to biological systems. Effects of plasma 
exposure are observed to millimetre depths within tissue. However, the exact nature 
of the initial plasma-tissue interactions remains unknown, including RONS speciation 
and delivery depth, or how plasma-derived RONS intervene in biological processes. 
Herein, we focus on current research using tissue and cell models to learn more 
about the plasma delivery of RONS into biological environments. We argue this 
research is vital in furnishing an underpinning knowledge required to realise the full 
potential of plasma in biology and medicine.  
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Why the interest in cold atmospheric plasma in biological and medical 
sciences? 
Over the past two decades interest in the application of cold atmospheric plasma 
(herein referred to as plasma) in biology and medical sciences has been rapidly 
growing. There is significant optimism that plasma can be developed for a wide 
range of medical applications such as for the treatment of chronic wounds [1], 
cancers [2], dental decays [3] and dermatological indications [4]. In biotechnology, 
plasma is being investigated for enhancing cell transfection efficiency [5-7], stem 
cell differentiation [8] and tissue regeneration [9]. A number of plasma sources 
are being commercialized for medical use [10, 11]; these sources are being 
extensively characterized and optimized to ensure they can be applied safely to 
tissue [4, 10]. Significant progress in the applications of plasma has opened a new 
research field termed plasma medicine; with the core being the use of cold 
atmospheric plasma (as opposed to thermal plasma) to intervene in biological 
processes for improving medical outcomes. 
 
In parallel, plasma is being applied to animal and plant tissues to enhance the quality 
and value of foods (meats, fruits and vegetables) [12], improve seed germination and 
plant growth [13, 14] and treat plant disease [15]. Plasma is attractive as it is cost 
effective, does not necessarily change the edible qualities of food, increases food 
shelf-life and can be applied to packaged food [16, 17]. Moreover, plasma addresses 
food safety problems, such as the reduction of salmonella infections on egg shells in 
Europe [18]. 
 
Although plasma research (applied to tissues and cells) has advanced in Europe, 
South East Asia and USA, we argue that there is an urgent need almost to ‘double-
back’ and with a renewed focus on the fundamentals of how plasma interacts with 
tissues. This is a topic that we consider has been largely been overlooked 
worldwide: yet is crucial in both the context of health and disease in human tissue 
[19] and in the deactivation of microbes on food products [20, 21].   
 
The purpose of this Opinion Article is to put a unique focus on the speciation 
and transport of plasma-generated RONS in tissue and cells. We will argue 
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that such a focus will furnish vital underpinning knowledge that will help put 
plasma technologies on a firmer scientific footing. 
 
Plasma as a source of RONS 
Our starting point is that when plasma reacts with the ambient air, it generates a rich 
mixture of reactive oxygen species (ROS) and reactive nitrogen species (RNS), or 
collectively RONS, which are most likely to play the major role in the phenomenon 
described to date [22]. Although we readily acknowledge possible contributions from 
other plasma constituents, such as photons, metastables, charged species and 
strong electric fields [19, 23], these are outside the scope of this opinion article.  
 
In the context of human health, historically, RONS have been thought to be ‘bad’ and 
associated with free-radical ageing; but current thought now focuses on the role of 
RONS in a myriad of biological processes that are implicated in the protection and 
repair of cells and/or organisms [24]. And, whilst large doses of RONS to any 
cell/organism are no doubt ‘harmful’, the delivery of small doses of specific RONS 
could be beneficial in the treatment of a wide range of indications [22, 24].  For 
example, wound healing can be enhanced by small doses of exogenous H2O2, but 
higher doses delay wound healing [25]. The efficacy of plasma (when applied to 
tissue) is almost always linked to RONS that are naturally produced in vivo. And the 
argument follows that RONS regulate key biochemical pathways within intra- and 
intercellular environments, inducing chemical and physical changes in cells [22, 24].  
 
But, the intervention of plasma-generated RONS in cellular processes 
assumes a priori the availability of RONS. This is quite an assumption considering 
the relatively short lifetime and diffusion distances and high reactivity of many 
plasma-generated RONS; e.g., the OH is calculated to have a lifetime of 10-9 
seconds with a diffusion distance of 0.009 micrometres within mammalian cells [26]. 
However, even before the plasma-generated RONS enter cells, the RONS need to 
traverse at least three major barriers at the (1) plasma-fluid, (2) tissue fluid-tissue 
and (3) tissue-cell (Figure 1) interfaces, before finally reaching the cell interior. 
During their passage through the physiological environment, RONS will face 
additional obstacles such as extracellular matrix (ECM) proteins and antioxidants. 
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Therefore, it is remarkable how plasma can essentially non-invasively destroy cells 
deep within biofilms [27] or cancerous tumours [28] when these cells may be 
buried tens of micrometres to even millimetres away from surfaces directly 
accessible to plasma.  
 
Computational modelling has been utilised to provide further insight into the plasma 
delivery of RONS into tissue fluid and tissue [29, 30]. These simulations determined 
that plasma can deliver O3, H2O2 and NOx to tissue covered with a thin liquid layer; 
but the presence of alkane-like hydrocarbons in physiological fluid can inhibit the 
delivery of ROS [29]. In biofilms, H2O2 and O2 can potentially quite deep to millimetre 
depths, whereas the penetration depth of other ROS such as O3 was limited to 5-40 
micrometres [30].  
 
To detect the plasma-generated RONS in aqueous solution, ESR [31, 32], LC-MS 
[33, 34] and UV-Vis [35-37] are often used. Usually ESR is used to measure short-
lived RONS in aqueous solutions treated by plasma (including the OH• with a lifetime 
of < 100 microseconds, ONOOH with lifetime of ~1 millisecond, and O2
- and HOO• 
with lifetimes < 10 seconds). However, the consensus is that the shorter-lived RONS 
rapidly decay in aqueous solution to give more stable longer-lived secondary RONS 
such as NO2
-, NO3
- and H2O2; these RONS have been readily detected by LC-MS, 
FT-IR, and UV-Vis analysis of plasma treated aqueous solutions.  
 
Aggregated, these data lead to a number of obvious questions: 
 What RONS, originating from plasma (or RONS produced downstream), are 
delivered into real biological targets (animal, food product, plant) and how far are 
they delivered?   
 How do these RONS interact with the various components of a real tissue, e.g. in 
an animal, tissue fluid, extracellular matrix, cell membranes and intracellular 
components.  
 
Herein, we describe the progress made to date in developing models to measure the 
sub-surface (deeper than the top few nanometers to millimeters) interactions of 
RONS in tissues, and in the later section in cells. In order to reach the surface of 
Comment [MP1]: Two comments here: 
first, “lifetime” is a bit ambiguous. Do you 
mean “half-life”? Second, can you include 
citations for these numbers?  
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and/or penetrate a target cell interior, we argue that three major interfaces must be 
breached (shown in Figure 1). In the case of more complex ‘targets’, such as cancer 
with an associated wound, there may be clotted blood, pus and wound debris (Figure 
1). 
 
Experimental and simulation studies clearly show that deeper within tissue fluid and 
tissue (millimetres below the surface) most of the RONS from the plasma-air 
interface are converted to more stable RONS with a longer half-time – usually H2O2, 
NO2
-, NO3
-, as well as O2 [35, 36, 38]. These RONS are produced in the liquid phase 
from chemical reactions with neighbouring RONS and also with the constituents of 
the tissue fluid and tissue. Plasma treatment can also stimulate the intracellular 
production of RONS, which may amplify the original RONS dosage delivered by 
plasma into tissue fluid and tissue [39, 40].  
 
Delivery of RONS into tissue – the gap in our knowledge 
Leading experts in plasma biotechnology have argued that plasma stimulates tissue 
sub-surface by cell-to-cell communication – whereby only surface cells are directly 
exposed to the plasma (or effluent) and any subsurface effects are transmitted from 
these cells [41-43]. This explanation fits with biological theory. But it still cannot 
explain how the RONS reach the surface layer of cells in the first place. What is 
perhaps a little underappreciated is that in open wounds (Figure 1) there are major 
physical barriers to traverse, comprising congealed blood and pus from infections. 
For further information, refer to figures 1-4 in reference [44]. 
 
In this opinion article, we are concerned with the transport of more stable RONS into 
tissue and these RONS interacting with the first ‘physical barrier’ of the cell (i.e. the 
phospholipid cell membrane). This is not to minimise the importance of, for example, 
RONS-DNA interactions – which could have significant implications for the safety of 
plasma treatments (e.g. chromosomal stability and genotoxicity [45, 46]) – but are 
outside of the scope of this article. 
 
Delivery of RONS into tissue models 
One first step toward modelling RONS penetration and delivery into tissue was a 
simple experiment using a plasma jet and a gelatin target with embedded 
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phospholipid vesicles [47]. The vesicles encapsulated a self-quenched dye that 
when released (upon vesicle destruction) resulted in a clear fluorescence switch-on. 
These very first data showed that a plasma jet could interact (disrupt) phospholipid 
cell membranes at least several hundred micrometres below soft hydrated material. 
A second follow-up study showed that the spatial surface distribution and penetration 
depth of plasma-generated RONS was very similar to the patterns observed for 
vesicle destruction [48]; and prolonged treatment enabled ROS to be delivered to 
millimetre depths in the gelatin target by the plasma jet. Apart from two initial studies 
by Fridman and colleagues using agarose tissue models [49, 50], there do not 
appear to have been any earlier similar studies on tissue penetration. 
 
This was surprising because in the development of any new medical therapy, usual 
questions asked at some point (and often asked by the regulator) concern: 
 
 What are the active species?  
 What is the mode of action?   
 What are the safe doses?   
 
These questions need to be addressed in the development of any new medical 
therapies. In plasma medicine, knowledge of the plasma-phase species is important, 
but knowledge of those delivered into any biological system is vital.   
 
A subsequent development to the approach described above used gelatin and 
agarose model targets with either embedded chemical reporters, or simply as films 
through which plasma-generated RONS traverse, to measure RONS speciation and 
delivery into and through tissues [36, 37, 48, 51-54]. In the latter case, UV-Vis 
spectroscopy was used to identify RONS that traverse the targets. Gelatin was 
chosen because it consists of collagen, which is a major protein in skin, bone and 
connective tissue [55]; gelatin also provides a barrier to H2O2 (when spotted as 
solution on top of the gelatin surface) and potentially to other RONS [48]. Agarose 
was chosen because it has been widely utilised to mimic different tissue types (e.g. 
skin, liver, brain) [56, 57] and has been utilised as a tissue model for studies in 
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radiotherapy and neuroscience [58, 59]. The physicochemical properties of gelatin 
and agarose can easily be tailored for specific applications.  
 
Experiments with the tissue models have revealed the key RONS delivered into 
tissue (speciation) and likely relative (but not absolute) concentrations (doses) and 
depths of delivery. From these findings it is clear that plasma treatment can induce 
physical and chemical modifications deep within tissue to millimetre depths. Since 
our earlier studies, other groups have started utilising gelatin and agarose tissue 
models with different plasma sources and also observed relatively deep penetration 
of RONS to millimetre depths [60, 61].  
 
However, whilst they are useful for gaining new insights into plasma-tissue 
interactions, these models are relatively poor mimics of real animal tissues, lacking 
proteins, enzymes, antioxidants, cells, or a heterogeneous structure (e.g. skin layers: 
epidermis, dermis, hypodermis). And current tissue models do not mimic the 
gelatinous-like structure of biofilms. Building in these ‘features’ of real tissues would 
provide much more robust models to explore the plasma delivery of RONS into 
tissue. Very realistic 3D models of mammary glands [62] and the extracellular matrix 
[63, 64] have been developed in recent years; future plasma medicine research 
should adopt these models.   
 
Concomitant with RONS delivery, plasma jets were also shown to oxygenate the 
tissue models [36, 52, 54]. Tissue oxygenation with a plasma jet has also been 
observed in vivo by Collet and colleagues, who have shown that a plasma jet 
induces tissue oxygenation in live mice [65]. This result suggests that plasma jets 
can counteract hypoxia, a phenomenon that impedes healing in chronic wounds and 
increases resistance of cancer cells to radiation and cytotoxic drugs [66].  
 
However, as noted above, we expect that gelatin would present a barrier to H2O2 
[48], and by inference to other RONS. Therefore, an important question arises: what 
is the ‘force’ that is responsible for the plasma delivery of RONS across what should 
be an impenetrable barrier? We argue electric fields from the plasma jet have an 
important role. One study observed that plasma jets deliver RONS onto the surface 
of gelatin tissue models in a star-shaped pattern [48]. Similar star-shaped patterns 
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were observed for plasma surface streamers across insulators as measured by 
Pockels sensing and seen in Litchenberg figures [67]. Recently, it was shown that 
a relatively small electric field of 20 V cm−1 can significantly enhance the plasma 
delivery of RONS into a gelatin tissue model [60]. These results indicate that electric 
fields facilitate the plasma delivery of RONS into real biological tissue. However, the 
data is still relatively sparse, so the results are obviously far from conclusive and 
much further work is needed to understand mechanisms that drive plasma-
generated RONS deep into tissues.  
 
Crossing the cell membrane barrier 
The phospholipid membrane provides a barrier to exogenous RONS. Understanding 
plasma-generated RONS interactions with cell membranes is vital to developing a 
fuller mechanistic picture of how plasma potentially stimulates cells. Broadly, one of 
two events can occur when RONS encounter the cell membrane: (i) RONS can react 
with the cell membrane, or (ii) RONS cross the cell membrane (Figure 2). With 
renewed interest and research dedicated towards elucidating the molecular 
mechanisms of lipids in their contribution to diseases, there is growing optimism that 
new and more effective approaches can be obtained to prevent and cure diseases 
such as cancers [68]. 
 
Computer simulation experiments have improved our understanding of plasma 
interactions with cell membranes. For example, molecular dynamic simulations have 
shown that reactions of RONS with the cell membrane lead to lipid peroxidation, 
enhancing the ingress of further RONS (Figure 2) [69]. Electric fields from plasma 
can also act in synergy with plasma-generated RONS increasing membrane 
permeability [70]. Cholesterol in healthy cell membranes can significantly reduce the 
ingress of RONS, which is particularly important for targeted cancer therapy because 
cancer cells generally have a lower percentage of cholesterol in their cell membrane 
[69].  
 
Computer simulations have been supported by experiments with models of cell 
membranes [71-74]. Other results showed that plasma can directly deliver RONS 
across phospholipid membranes in simple buffers and in proteinaceous solutions 
required for in vitro cell culture [75-77]. These studies tailored the vesicle diameter to 
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mimic eukaryotic and prokaryotic cells and observed that due to the large differences 
in the surface area:volume ratio, plasma delivers a higher dosage of RONS into 
prokaryotic cells, which is important for decontamination of wounds infected with 
bacteria [75]. 
 
Whilst these approaches have yielded valuable insights into how lipids and 
cholesterol in cell membranes react with and influence the ingress of RONS into the 
cell interior, there are a number of clear limitations in current simulations. These 
include: 
 Real cell membranes are made up of many different lipids (rather than one or two 
typically used in computational and experimental models). In fact, eukaryotic cells 
synthesise thousands of different lipids [78]. 
 Different healthy cell types have membranes that differ significantly in 
composition. The variability in cell membranes is further complicated in diseased 
cells, where membrane composition can change with disease status, e.g. in 
cancer cells [68]. 
 Eukaryotic cells possess internal membranes that encase their nucleus and 
organelles with each membrane being different in composition and function. This 
further increases the complexity of the cell membrane properties that present a 
barrier to RONS (i.e. nuclear and organelle membranes). 
 Cell membranes are dynamic and can self-repair. 
 Real cell membranes contain proteins and are decorated by complex sugars. 
 Cell membranes contain channels that actively move molecules in and out 
(Figure 2), such as aquaporins [79]. 
  
Some of this complexity could be readily incorporated into synthetic cell membranes, 
such as more complex lipid compositions. Other features, e.g. the decoration by 
complex sugars, would require considerably more thought about how to achieve. 
Further aspects, such as ion channels, may not be technologically achievable at this 
point in time and we would consider, at least for present, it would perhaps be better 
to progress to real cells.  
 
Are plasma-generated RONS really intervening in biological processes? 
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One significant challenge we have already highlighted is to demonstrate that it is 
indeed the plasma-generated RONS (or its progeny) that ultimately ‘intervenes’ in a 
biological pathway, whether intra- or intercellular, to bring about some upstream 
medical outcome. In this respect, more sophisticated tissue models (e.g. with 
embedded cells) and models of cell membranes could be very powerful. Adapting 
the method of Gorbanev and colleagues [80], using isotopically labelled reagents in 
either the gas feed, or ambient atmosphere, it should be possible to determine both 
the origin and final fate of specific RONS, from the plasma into individual cells.  
 
Eventually, pre-clinical models will be required to validate any results generated with 
the tissue/cell models. But we argue that tissue/cell models will always remain 
important tools in plasma medicine research because they enable more time and 
cost effective experimentation and reduce the number of animal experiments, which 
would also eliminate unnecessary animal suffering. 
 
Concluding remarks and future directions 
A better understanding of plasma-tissue/cell interactions will enable us to develop 
plasma applications that are safer, more robust and effective. Simple models of 
tissue and cells will aid in developing this understanding. Future research with these 
models could address some important questions (see Outstanding Questions). In 
answering these questions, the potential immediate impacts include: 
1. Plasma medicine and health – the long term goal (and major impact) is the use of 
plasma to synthetically generate RONS that intervene in known biological processes 
associated with disease or tissue regeneration. 
2. Food manufacturing – outside of medicine, a likely impact would be the use of 
RONS to enhance food manufacturing (meats, fruits and vegetables). 
 
In summary, developing synthetic models to mimic the chemical, physical and 
biological architecture of biological tissue remains a great challenge. But tissue 
models do offer advantages compared to experimentation with cells and animals 
including simpler, faster and more cost-effective experimentation, and avoid growing 
ethical concerns associated with animal experimentation. Incorporation of living cells 
into the tissue models is a logical next step to understand the role of cell-to-cell 
signalling in the plasma treatment of diseased tissue. Perhaps even more pertinent, 
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is the use of tissue models to unravel the role of electric fields in the delivery of 
RONS into tissue. Understanding how to effectively harness electric fields in plasma 
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Figure 1 (Key Figure). Cold atmospheric plasma jet delivery of RONS into a 
cancerous tumour with an associated wound. The plasma-generated RONS need to 
traverse at least three major interfaces before reaching the interior of a cancer cells 
(from top to bottom): (1) plasma-fluid, (2) tissue fluid-tissue and (3) tissue-cell. 
Cancerous tumours are often associated with ulcerous wounds consisting of 







Figure 2. Mechanisms by which plasma-generated RONS can cross a cell 
membrane barrier to reach the cell interior. In order from left to right: through a 
passive diffusion process, or through a membrane channel, or through pores 
generated by lipid oxidation. Strong electric fields (not shown on the illustration) from 




















 Physical effects of plasma can be seen to depths of several hundred 
micrometres within tissue. 
 Plasma-derived RONS are likely to be delivered millimetres into tissues. 
 Speciation reveals that RONS delivered by plasma into tissue fluid and tissue 
are predominately stable secondary RONS – e.g. H2O2, NO2
- and NO3
-. 
 The plasma generation of RONS within a hydrated target is influenced by the 
target matrix that can enhance or reduce the RONS concentrations and act as 
a reservoir RONS. 
 It is likely that the concentration of these plasma-derived RONS exceeds 
hundreds of micromoles, even at depths of several millimetres within tissue. 
 Oxygen concentration at the time of plasma treatment significantly influences 























OUTSTANDING QUESTIONS BOX 
 What are the kinetics and mechanisms in the transport of plasma-derived 
RONS into tissues and cells? And what proportion of these RONS originate 
from the plasma-phase versus secondary RONS? 
 Can we tailor plasma to deliver specific RONS to targeted depths and specific 
sites within tissue? 
 How does the biological target influence the speciation and depth in the 
plasma delivery of RONS? Do biological targets ‘quench’ RONS, or provide a 
reservoir/further source of secondary RONS? 
 Can we eventually describe plasma treatment in terms of a RONS dose 
(similar to a medical drug)? 
 Does plasma elevate intracellular RONS directly through the 
delivery/generation of RONS into cells, or indirectly through the modification 
of the extracellular matrix? 
 What is/are the responsible force(s) for the transport of primary or secondary 
plasma-derived RONS in tissue? Can we manipulate these to obtain more 
effective therapies? 
 How does the composition of the cell membrane influence the ingress of 
plasma-derived RONS into the cell interior? How important is the cell 
membrane composition compared to cell ion channels? 
 Can plasma-derived RONS cross internal cell membrane barriers?  
 Does the membrane surface area:cell volume ratio influence RONS ingress? 
This is particularly important for plasma decontamination of wounds infected 













Aquaporins Channels found on the cell membrane that help 
facilitate the passage of H2O2 into and out of the cell 
Cell transfection  
Cold atmospheric plasma Electrical plasma in the form of a partially ionized gas 
operated at atmospheric pressure without 
considerably heating the background gas above 
ambient temperature 
Biofilms Groups of adherent microorganisms (e.g. bacteria 
cells) forming colonies surrounded by a polymeric 
matrix 
Cell-to-cell communication  
ESR Electron spin resonance 
Free-radical ageing  
H2O2 Hydrogen peroxide 
HOO• Hydroperoxyl radical 
LC-MS Liquid chromatography mass spectrometry 





NOx Nitrogen oxides 




OH Hydroxyl radical 
ONOOH Peroxynitrous acid 
Plasma jet Cold atmospheric plasma typically formed in a 
dielectric tube with a flowing inert gas (e.g. helium or 
argon). The tube is open-ended enabling the plasma 
to extend into the ambient atmospheric giving a ‘jet-
like’ appearance.  
Plasma medicine Use of cold atmospheric plasma to induce a physical 
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or chemical change in tissue fluid, tissue or cells to 
induce a desired biological response or treat a 
disease. 
Pockels sensing  
RNS Reactive nitrogen species 
RONS Reactive oxygen and nitrogen species 
ROS Reactive oxygen species 
Stem cell differentiation  
Tissue regeneration  
Tumours Abnormal masses of tissue growth, which can be 
benign or cancerous 
UV-Vis Ultra-violet visible spectroscopy 
  
  
 
 
 
